Professional Documents
Culture Documents
Netter's Internal Medicine 2nd Ed 7
Netter's Internal Medicine 2nd Ed 7
( )
.
( ) ,
.
, . ,
: ( ),
( ) ( ). ,
1995, :
(ARVD:arrythmogenic right ventricular dysplasia) :
(ARVC:arrythmogenic right ventricular cardiomyopathy).
, .
, ,
A , .
.
, , ,
( . 33-2).
, . ( ), ,
. ( . . ,
, Herceptin).
, ( . .
(remodeling) ( . , , ,
33-1). , , ),
. , ( . .
- Wilson
),
( . 19), ( . . , , ),
. ( . .
, , )
,
Starling. , ( ).
, ( . . ,
. MELAS [mitochondrial encephalopathy, lactic acidosis,
( 33-1). stroke-like]
(” ).
”): ,
. ,
. ( 30%)
.
.
231
232 IV
33-1 , .
P
R
T
T
R R
(P)
(W) (R).
(T) .
L : , LV: ,
RA: , RV:
33-2 .
T
R
( )
Q ST
I aVR V1 V4
II aVL V2 V5
III aVF V3 V6
ST
3
33 233
33-1 -
- ,
. ’ ,
( )
*
.
( . . , Chagas, Lyme) ,
( . . , *, ,
, - , , ( . 33-3).
)
/ ( . . ,
,
, , Coxsackie B, , , , HIV
, ) ,
( . . Chagas (
, *, , )
, )
( . . Wilson, *,
Lyme.
*, *)
/ ( . . , ,
kwashiorkor, , - , ) .
. . Duchenne, Becker,
)
( . . X) .
,
*
. ,
( )
,
( . 33-4).
.
* .
*
,
*
( . . ) ,
*
* .
( . .
,
, Fabry,
Refsum, Niemann-Pick, Gaucher, ( . 33-1).
Hurler, Hand-Schüller-Christian)
( . . Noonan)
( ).
, ,
. (
)
,
.
,
,
*
. . ,
0,2%
( . . Duchenne, Becker), ,
X ( . . . ,
)
( . . .
A/C). ,
. .
234 IV
33-3 .
(x100)
Coxsackie
B. His,
, (x100)
(x100)
.
, :
. (ASH:asymmetric septal hypertrophy)
400 11 .
, :
- - , ,
T, I C, C, , ,
- , , ( 50 mm Hg)
. ( . 33-5).
.
, , ,
. , ,
, , , - ( )
, . , ,
(IHSS:idiopathic hypertrophic subaortic
stenosis) . . ,
, ,
,
33 235
33-4 .
(
)
( ) (
R V4, V5 V6, S V3R, V1, V2, III aVR, ST T
V5, V6, I, II, aVL aVF).
. , .
( 75% ). ,
,
Wolff-Parkinson-White. .
. .
.
, ( . . )
( ) . .
, ,
, ( . . , . 33-6),
, , -
“ ”,
. ( . . , ,
. ) ( . 33-1).
,
- (
236 IV
33-5 .
” ”
(jet lesions)
( )
Noonan ).
,
.
, . ,
, . ,
,
. (AL, ,
), .
,
,
. .
(AA, .
)
. . ,
,
, .
, .
,
. ,
( , ,
). .
1% .
,
. .
’ , ,
, .
( ). ,
,
,
, ( . .
. ),
, , .
, ,
, , .
. , .
33 237
33-6 .
” ” ,
(x540)
, ,
,
.
. , ,
,
.
( ), ,
( )
( ).
, , ,
. ,
,
. , , ,
( ), ,
;( 33-1). ,
.
238 IV
33-1 *
( )
,
±RBBB, PVCs
, , , ,
± ,
± , , ,
LVEF,
, ( ),
, LVEF,
LVOT
+
( ) LVOT
, ,
( )
(
, —
Coxsackie B
PCR
* /
ANA: antinuclear antibody ( ), ENA: extractable nuclear antigens ( ), HbA1c: A1c,
Ig: , LVEF: left ventricular ejection fraction ( ), LVOT: left ventricular out ow tract (
), PCR: polymerase chain reaction ( ), PVCs: premature ventricular contractions ( ),
RBBB: right bundle branch block ( ), SPEP: serum protein electrophoresis ( ), TSH: thyroid-
stimulating hormone ( ), UPEP: urine protein electrophoresis ( ), : , :
, . : / , . : /
, : , : , : , : , :
, : .
33 239
,
, .
. ,
, , . ,
. ,
19
American College of Cardiology/
American Heart Association Heart Faiure Society of ( ,
America,
, , ).
,
, ,
, , - . ,
, , D ( . .
, , : [VAD: ventricular
, assist device]
. ).
, .
, 73.000
. , 200
( . . . ,
, 2.000
), 134 .
, ,
( . . ,
). .
,
,
, ( . 33-7),
, ( ,
) . .
-
( ).
(30 1967,
Dr. Christiaan Barnard
, , ’
1968, Stanford
.
Dr. Norman Shumway),
,
,
.
.
.
( A) 1983,
.
,
.
,
plateau (
) 1990 (
Holter,
4.000 ),
,
. ,
, ( )
.
( 30mm).
240 IV
33-7 .
, -
. 10 .
,
, ( ) ,
NYHA (New York Heart Association) IV
, ,
-
.
.
,
,
, (
,
, . .
.
- ), ,
,
, ,
, ,
. ,
.
,
,
.
- ,
33 241
,
These guidelines provide current recommendations for treatment of
chronic heart failure based on available data and consensus opinion (class
. I, IIa, IIb, III; levels A, B, C).
3. Ho CY, Seidman CE: A contemporary approach to hypertrophic
. cardiomyopathy. Circulation 113(24):e858-e862, 2006.
This review provides an overview of hypertrophic cardiomyopathy
from a genetics perspective.
(ECMO:extracorporeal membrane 4. Hunt SA, Abraham WT, Chin MH, et al: ACC/AHA 2005
oxygenator) Guideline Update for the Diagnosis and Management of Chronic
(IABP:intraaortic balloon pumps)· Heart Failure in the Adult: A report of the American College of
. Cardiology/American Heart Association Task Force on Practice
Guidelines (Writing Committee to Update the 2001 Guidelines for
( ) the Evaluation and Management of Heart Failure). Developed in
collaboration with the American College of Chest Physicians and
, the International Society for Heart and Lung Transplantation,
, , . , endorsed by the Heart Rhythm Society. Circulation 112(12):
ECMO , e154-e235, 2005.
These guidelines provide current recommendations for treatment of
chronic heart failure based on available data and consensus opinion (class
. ( I, IIa, IIb, III; levels A, B, C).
) 2002, ’ 5. Jessup M, Banner N, Brozena S, et al: Optimal pharmacologic and
non-pharmacologic management of cardiac transplant candidates:
. , Approaches to be considered prior to transplant evaluation.
International Society for Heart and Lung Transplantation
. guidelines for the care of cardiac transplant candidates—2006. J
, Heart Lung Transplant 25(9):1003-1023, 2006.
, These guidelines provide current recommendations for optimizing
. treatment of patients being considered for heart transplantation based
, , on available data and consensus opinion (class I, IIa, IIb, III; levels A,
B, C).
. 6. Kushwaha SS, Fallon JT, Fuster V: Restrictive cardiomyopathy.
N Engl J Med 336(4):267-276, 1997.
This review provides an overview as well as the diagnostic and
, therapeutic approach to patients with restrictive cardiomyopathy based
on available data and consensus opinion.
. 7. Maron BJ: Hypertrophic cardiomyopathy: A systematic review.
JAMA 287(10):1308-1320, 2002.
This review provides an overview as well as the diagnostic and
, therapeutic approach to patients with hypertrophic cardiomyopathy based
. , on available data and consensus opinion.
, 8. Mehra MR, Kobashigawa J, Starling R, et al: Listing criteria for
, heart transplantation: International Society for Heart and Lung
Transplantation guidelines for the care of cardiac transplant
candidates—2006. J Heart Lung Transplant 25(9):1024-1042,
. , , 2006.
’ These guidelines provide current recommendations for evaluating
. patients for heart transplantation based on available data and consensus
opinion (class I, IIa, IIb, III; levels A, B, C).
9. Miller LW, Lietz K: Candidate selection for long-term left
ventricular assist device therapy for refractory heart failure. J
1. Gronda E, Bourge RC, Costanzo MR, et al: Heart rhythm Heart Lung Transplant 25(7):756-764, 2006.
considerations in heart transplant candidates and considerations This review outlines current strategies for evaluating patients being
for ventricular assist devices: International Society for Heart and considered for ventricular assist device support based on available data
Lung Transplantation guidelines for the care of cardiac transplant and consensus opinion.
candidates—2006. J Heart Lung Transplant 25(9):1043-1056, 10. Richardson P, McKenna W, Bristow M, et al: Report of the 1995
2006. World Health Organization/International Society and Federation
These guidelines provide current recommendations for optimizing of Cardiology Task Force on the Definition and Classification of
nonpharmacologic treatment of patients being considered for heart Cardiomyopathies. Circulation 93(5):841-842, 1996.
transplantation based on available data and consensus opinion for This paper outlines the classification of cardiomyopathies based on
electrophysiologic devices and mechanical ventricular assist device support expert consensus opinion.
(class I, IIa, IIb, III; levels A, B, C).
2. Heart Failure Society of America: Executive summary: HFSA
International Society of Heart and Lung Transplantation. Available at:
2006 Comprehensive Heart Failure Practice Guideline. J Card
http://www.ishlt.org. Accessed December 22, 2006.
Fail 12(1):10-38, 2006.
This website contains many helpful resources about heart, heart-lung, and
lung transplantation for health professionals, patients, and their families.
Heart Failure Society of America. Available at: http://www.hfsa.org. United Network of Organ Sharing. Available at: http://www.unos.org.
Accessed December 22, 2006. Accessed December 22, 2006.
This website contains many helpful resources about heart failure for health This website contains many helpful resources about organ transplantation in
professionals, patients, and their families. the United States for health professionals, patients and their families.